News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
347,150 Results
Type
Article (20112)
Company Profile (138)
Press Release (326900)
Multimedia
Podcasts (56)
Webinars (11)
Section
Business (107911)
Career Advice (731)
Deals (25215)
Drug Delivery (79)
Drug Development (43140)
Employer Resources (65)
FDA (8115)
Job Trends (8225)
News (188839)
Policy (17545)
Tag
Academia (842)
Accelerated approval (3)
Adcomms (7)
Allergies (46)
Alliances (28456)
ALS (52)
Alzheimer's disease (537)
Antibody-drug conjugate (ADC) (92)
Approvals (8175)
Artificial intelligence (213)
Autoimmune disease (13)
Automation (9)
Bankruptcy (194)
Best Places to Work (6030)
BIOSECURE Act (10)
Biosimilars (64)
Biotechnology (66)
Bladder cancer (29)
Brain cancer (23)
Breast cancer (158)
Cancer (1198)
Cardiovascular disease (109)
Career advice (637)
Career pathing (18)
CAR-T (61)
CDC (5)
Cell therapy (175)
Cervical cancer (13)
Clinical research (36411)
Collaboration (581)
Company closure (1)
Compensation (221)
Complete response letters (18)
COVID-19 (1096)
CRISPR (33)
C-suite (183)
Cystic fibrosis (54)
Data (1293)
Denatured (15)
Depression (24)
Diabetes (138)
Diagnostics (2394)
Digital health (12)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (93)
Drug pricing (86)
Drug shortages (15)
Duchenne muscular dystrophy (55)
Earnings (41356)
Editorial (19)
Employer branding (6)
Employer resources (59)
Events (45603)
Executive appointments (538)
FDA (8905)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (409)
Gene editing (66)
Generative AI (16)
Gene therapy (164)
GLP-1 (487)
Government (1821)
Grass and pollen (3)
Guidances (113)
Healthcare (6431)
Huntington's disease (5)
IgA nephropathy (23)
Immunology and inflammation (58)
Immuno-oncology (4)
Indications (22)
Infectious disease (1158)
Inflammatory bowel disease (80)
Inflation Reduction Act (6)
Influenza (23)
Intellectual property (80)
Interviews (108)
IPO (8104)
IRA (36)
Job creations (2476)
Job search strategy (554)
Kidney cancer (7)
Labor market (20)
Layoffs (276)
Leadership (7)
Legal (4446)
Liver cancer (31)
Lung cancer (178)
Lymphoma (104)
Machine learning (5)
Management (20)
Manufacturing (254)
MASH (46)
Medical device (3995)
Medtech (3997)
Mergers & acquisitions (17629)
Metabolic disorders (395)
Multiple sclerosis (44)
NASH (14)
Neurodegenerative disease (49)
Neuropsychiatric disorders (16)
Neuroscience (860)
NextGen: Class of 2025 (2610)
Non-profit (1247)
Now hiring (12)
Obesity (217)
Opinion (162)
Ovarian cancer (30)
Pain (75)
Pancreatic cancer (41)
Parkinson's disease (75)
Partnered (12)
Patents (178)
Patient recruitment (56)
Peanut (16)
People (33624)
Pharmaceutical (70)
Pharmacy benefit managers (16)
Phase I (9775)
Phase II (15559)
Phase III (13600)
Pipeline (874)
Policy (102)
Postmarket research (1571)
Preclinical (4053)
Press Release (28)
Prostate cancer (70)
Psychedelics (10)
Radiopharmaceuticals (152)
Rare diseases (244)
Real estate (3221)
Recruiting (22)
Regulatory (12513)
Reports (24)
Research institute (889)
Resumes & cover letters (108)
Rett syndrome (8)
RNA editing (5)
RSV (15)
Schizophrenia (64)
Series A (82)
Series B (38)
Service/supplier (5)
Sickle cell disease (36)
Special edition (9)
Spinal muscular atrophy (90)
Sponsored (13)
Startups (2126)
State (2)
Stomach cancer (3)
Supply chain (43)
Tariffs (43)
The Weekly (39)
Vaccines (286)
Venture capital (23)
Weight loss (139)
Women's health (10)
Worklife (5)
Date
Today (52)
Last 7 days (259)
Last 30 days (1260)
Last 365 days (15957)
2025 (7895)
2024 (17248)
2023 (19097)
2022 (26260)
2021 (27155)
2020 (25752)
2019 (21112)
2018 (16702)
2017 (17732)
2016 (16592)
2015 (19402)
2014 (15359)
2013 (13027)
2012 (13921)
2011 (14539)
2010 (13303)
Location
Africa (412)
Alabama (20)
Alaska (2)
Arizona (88)
Arkansas (6)
Asia (24671)
Australia (3334)
California (2918)
Canada (1292)
China (384)
Colorado (120)
Connecticut (150)
Delaware (95)
Europe (50537)
Florida (539)
Georgia (80)
Idaho (21)
Illinois (296)
India (18)
Indiana (204)
Iowa (3)
Japan (153)
Kansas (67)
Kentucky (20)
Louisiana (8)
Maine (11)
Maryland (402)
Massachusetts (2375)
Michigan (80)
Minnesota (142)
Mississippi (1)
Missouri (35)
Montana (12)
Nebraska (8)
Nevada (20)
New Hampshire (19)
New Jersey (1202)
New Mexico (10)
New York (862)
North Carolina (628)
North Dakota (4)
Northern California (1178)
Ohio (94)
Oklahoma (5)
Oregon (19)
Pennsylvania (730)
Puerto Rico (13)
Rhode Island (17)
South America (662)
South Carolina (11)
Southern California (1179)
Tennessee (87)
Texas (393)
United States (11923)
Utah (73)
Virginia (108)
Washington D.C. (46)
Washington State (218)
West Virginia (3)
Wisconsin (35)
347,150 Results for "arcutis pharmaceuticals acquired by valeant pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
June 9, 2025
·
8 min read
Press Releases
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
June 16, 2025
·
17 min read
Press Releases
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
May 29, 2025
·
2 min read
Press Releases
Arcutis Announces Chief Financial Officer Transition
April 11, 2025
·
6 min read
Press Releases
Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update
May 7, 2025
·
11 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025
June 9, 2025
·
2 min read
Press Releases
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
June 9, 2025
·
11 min read
Press Releases
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
May 14, 2025
·
5 min read
Press Releases
Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference
March 28, 2025
·
2 min read
Press Releases
Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral and Detoxification Markets
June 4, 2025
·
8 min read
1 of 34,715
Next
